Blueprint Medicines(BPMC.US) Officer Sells US$7.71 Million in Common Stock

$Blueprint Medicines(BPMC.US)$ Officer Durso-Bumpus Debra sold 74,034 shares of common stock on Jun 21, 2024 at an average price of $104.19 for a total value of $7.71 million.Source: Announcement What

Futu NewsJun 26 04:39

Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing

Debra Durso-Bumpus, Chief People Officer, on June 21, 2024, sold 74,034 shares in Blueprint Medicines (BPMC) for $7,713,537. Following the Form 4 filing with the SEC, Durso-Bumpus has control over a t

MT NewswiresJun 26 04:13

Form 144 | Blueprint Medicines(BPMC.US) Officer Proposes to Sell 9.23 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 21, $Blueprint Medicines(BPMC.US)$ Officer Debra Bumpus intends to sell 87,034 shares of its common stock on Jun 21, with a total market value of approximately $9.23 millio

Futu NewsJun 22 05:57

Investing in Blueprint Medicines (NASDAQ:BPMC) a Year Ago Would Have Delivered You a 78% Gain

The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by picking above-average stocks. To wit, the Blueprint Medicines Corporation (NASDA

Simply Wall StJun 11 23:44

Unusual Options Activity: APA, LNG and Others Attract Market Bets, APA V/OI Ratio Reaches 420.0

EST Jun 11th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O

Futu NewsJun 11 23:30

Wells Fargo Maintains Blueprint Medicines(BPMC.US) With Buy Rating

Wells Fargo analyst Derek Archila maintains $Blueprint Medicines(BPMC.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 40.2% and a total average return of 5.6% over

Futu NewsJun 8 20:33 · Ratings